- Home
- OKYO vs NCSM Comparison
OKYO vs NCSM Comparison
Compare OKYO & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- NCSM
- Stock Information
- Founded
- OKYO 2007
- NCSM 2006
- Country
- OKYO United Kingdom
- NCSM United States
- Employees
- OKYO N/A
- NCSM N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- NCSM Oilfield Services/Equipment
- Sector
- OKYO Health Care
- NCSM Energy
- Exchange
- OKYO Nasdaq
- NCSM Nasdaq
- Market Cap
- OKYO 85.0M
- NCSM 76.3M
- IPO Year
- OKYO 2022
- NCSM 2017
- Fundamental
- Price
- OKYO $2.09
- NCSM $47.16
- Analyst Decision
- OKYO Strong Buy
- NCSM
- Analyst Count
- OKYO 1
- NCSM 0
- Target Price
- OKYO $7.00
- NCSM N/A
- AVG Volume (30 Days)
- OKYO 76.8K
- NCSM 19.6K
- Earning Date
- OKYO 07-18-2025
- NCSM 10-29-2025
- Dividend Yield
- OKYO N/A
- NCSM N/A
- EPS Growth
- OKYO N/A
- NCSM N/A
- EPS
- OKYO N/A
- NCSM 4.71
- Revenue
- OKYO N/A
- NCSM $175,468,000.00
- Revenue This Year
- OKYO N/A
- NCSM $9.11
- Revenue Next Year
- OKYO N/A
- NCSM $7.13
- P/E Ratio
- OKYO N/A
- NCSM $9.71
- Revenue Growth
- OKYO N/A
- NCSM 19.31
- 52 Week Low
- OKYO $0.90
- NCSM $16.81
- 52 Week High
- OKYO $3.35
- NCSM $51.49
- Technical
- Relative Strength Index (RSI)
- OKYO 32.76
- NCSM 65.62
- Support Level
- OKYO $2.11
- NCSM $40.99
- Resistance Level
- OKYO $2.39
- NCSM $51.49
- Average True Range (ATR)
- OKYO 0.16
- NCSM 3.22
- MACD
- OKYO -0.01
- NCSM 0.55
- Stochastic Oscillator
- OKYO 6.22
- NCSM 69.97
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.